Skip to main content

We Treat Hep C - Resources for Michigan Providers

Test. Treat. CURE.

Join the effort to eliminate Hep C in all Michiganders

Any provider with prescriptive authority can cure hepatitis C. To eliminate HCV in Michigan, MDHHS launched the We Treat Hep C Initiative in 2021. We Treat Hep C aims to increase access to HCV treatment among Michigan Medicaid and Healthy Michigan Plan beneficiaries by removing barriers to curing hepatitis C. 

When prescribing Mavyret® for Medicaid and Healthy Michigan Plan beneficiaries: 

  • Prior authorization is not required
  • Submission of sobriety, a specialist prescriber, and liver fibrosis score ≥ 0 are not required
  • Providers should order the entire course of Mavyret® indicating an 8- or 12-week supply.
    • *Specialty or retail pharmacies are authorized to dispense up to 102 days of therapy at a single time but default to dispensing in 4-week increments unless otherwise indicated.

When prescribing non-preferred direct-acting antivirals: 

Learn about Hepatitis C testing and treatment

FAQ - Frequently asked questions on We Treat Hep C, including clinical questions.

We Treat Hep C Clinician Newsletter (March 2024) - E-newsletter that features a hepatitis C provider spotlight and hepatitis C testing and treatment resources